Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Find out which cash back cards offer the best options for 2023. Stay updated with the latest offerings to maximize your rewards.
26,992 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
What’s going with stock? AMD is riding a data center and AI wave. This guide breaks down the drivers, risks, and real...
Apyx Medical (APYX) 2026 is shaping up as a pivotal year for investors. This guide breaks down how to read the Q1 tra...
Enbridge approaches its 52-week high as cash flow strengthens and a robust project backlog fuels optimism. Analysts c...
Amazon faces a cash-heavy growth cycle as cloud demand and custom chips drive revenue. The market clamps down on near...
Two retail powerhouses deliver contrasting plays for 2026: Amazon bets big on AI and cloud infrastructure, while Walm...
Coca-Cola and Philip Morris International both beat expectations in Q1 2026 and now sit near 52-week highs. Analysts ...
When a Tanger director cashed $518,000, investors take notice. This article breaks down insider trades, what signals ...
Advanced Micro Devices stock dropped sharply last month as tech valuations cooled. This guide breaks down the drivers...
A dividend ETF with a 19-year monthly payout streak stands out in 2026 for steady income. Here’s how this 5-star pays...
As regulators eye crypto privacy tools, the DOJ's push for an October retrial in the Tornado Cash case tests how far ...
Jim Cramer warns that AppLovin's blistering margins could attract a Google-sized challenger in ad tech. The alert fol...